Novartis (NVS)
(Delayed Data from NYSE)
$110.32 USD
+0.39 (0.35%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $110.30 -0.02 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth A Momentum C VGM
Brokerage Reports
Novartis AG [NVS]
Reports for Purchase
Showing records 461 - 478 ( 478 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Jan. 17
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Nov. 8
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New and Recent Drug Launch Weekly Retail Sales Tracker
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
New Drug Launch Weekly Retail Sales Tracker - Week Ended June 21
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week Ending May 10
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week ending February 22, 2013
Provider: WEDBUSH SECURITIES INC.
Analyst: MARAI C
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Griffin Securities Updates Coverage on Ligand Pharma. (LGND)
Provider: GRIFFIN SECURITIES, INC.
Analyst: MARKEY K
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology / Biopharmaceuticals -Preview of Gout Abstracts at the Upcoming ACR
Provider: WEDBUSH SECURITIES INC.
Analyst: XU Y
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Calendar of Events
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
RISK ARB TRADING UPDATE.
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
MERGERS & ACQUISITIONS
Provider: WALL STREET ACCESS CORP.
Company: Novartis AG
Industry: Medical - Drugs
Company: Novartis AG
Industry: Medical - Drugs
Novartis agrees to exercise its call option to buy remainder of Alcon''s shares
Provider: IIR GROUP
Analyst: KHAN F